Reckitt Benckiser sells E45 brand to Karo Pharma for £200mn
SLOUGH, UK: Reckitt Benckiser Group has entered into an agreement for the proposed sale of its E45 brand and related sub-brands to Karo Pharma for an implied enterprise value of £200 million. For the financial year ended 31 December 2020,…